Depot injection. A depot injection is an injection, usually subcutaneous, intradermal, or intramuscular, that deposits a drug in a localized mass, called a depot, from which it is gradually absorbed by surrounding tissue. Such injection allows the active compound to be released in a consistent way over a long period.
The Vanquish TM is a tunable, focused bipolar radiofrequency device which is FDA-approved for deep tissue heating. The deep tissue heating preferentially focuses in on the fat layer, and causes it to shrink by causing most of the fat cells to die off.
FDA Approves Repatha (evolocumab) Pushtronex - First And Only Single Monthly Injection for a PCSK9 Inhibitor: Aug 27, 2015: FDA Approves Repatha (evolocumab) to Treat Certain Patients with High Cholesterol: Apr 29, 2015: Amgen Announces FDA Advisory Committee Meeting to Review Repatha (Evolocumab) for High Cholesterol: Mar 15, 2015